Guided Therapeutics (GTHP) Times Interest Earned (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Times Interest Earned for 16 consecutive years, with -$3.86 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned rose 3.17% to -$3.86 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.84 through Dec 2025, up 30.55% year-over-year, with the annual reading at -$3.84 for FY2025, 30.52% up from the prior year.
  • Times Interest Earned hit -$3.86 in Q4 2025 for Guided Therapeutics, down from -$3.76 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$0.82 in Q3 2021 to a low of -$21.81 in Q2 2023.
  • Historically, Times Interest Earned has averaged -$6.52 across 5 years, with a median of -$5.03 in 2025.
  • Biggest five-year swings in Times Interest Earned: crashed 863.18% in 2022 and later skyrocketed 59.96% in 2024.
  • Year by year, Times Interest Earned stood at -$4.35 in 2021, then tumbled by 211.33% to -$13.54 in 2022, then soared by 50.26% to -$6.74 in 2023, then surged by 40.84% to -$3.99 in 2024, then grew by 3.17% to -$3.86 in 2025.
  • Business Quant data shows Times Interest Earned for GTHP at -$3.86 in Q4 2025, -$3.76 in Q3 2025, and -$4.86 in Q2 2025.